These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7215535)

  • 21. [Study of the quality of laboratory chemicals and reagents and diagnostic solutions].
    Voldán B; Sarsúnová M; Szücsová S
    Cesk Farm; 1969; 18(7):324-8. PubMed ID: 5349334
    [No Abstract]   [Full Text] [Related]  

  • 22. A new coincidence model for single particle counters, Part I: Theory and experimental verification.
    Knapp JZ; Abramson LR
    J Pharm Sci Technol; 1994; 48(3):110-34. PubMed ID: 8069513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parenteral formulations. I. Comparison of accelerated stability data with shelf-life studies.
    Lin SL
    Bull Parenter Drug Assoc; 1969; 23(6):269-88. PubMed ID: 5355889
    [No Abstract]   [Full Text] [Related]  

  • 24. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 25. Program for bacterial surveillance of intravenous admixtures.
    Ravin R; Bahr J; Luscomb F; Gooch J; Mutter S; Spittell SD
    Am J Hosp Pharm; 1974 Apr; 31(4):340-7. PubMed ID: 4822023
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of the first 6 months' experience in the monitoring of the sterility of injectable solutions].
    Pappalardo G
    Rev Med Suisse Romande; 1986 Feb; 106(2):163-71. PubMed ID: 3515496
    [No Abstract]   [Full Text] [Related]  

  • 27. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 28. Particulate matter counting: the technical issues.
    Knapp JZ
    J Parenter Sci Technol; 1988; 42(1):2-8. PubMed ID: 3361403
    [No Abstract]   [Full Text] [Related]  

  • 29. Panel discussion: Proposed changes in the USP--microbiological aspects. 3. Proposed microbial limit tests.
    Vera HD
    Bull Parenter Drug Assoc; 1969; 23(6):257-60. PubMed ID: 4901568
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recent aspects of the microbiological contamination of pharmaceutical products and their microbiological specification (author's transl)].
    Kurata H; Ishizeki C; Udagawa S
    Eisei Shikenjo Hokoku; 1978; (96):1-26. PubMed ID: 373832
    [No Abstract]   [Full Text] [Related]  

  • 31. PDA particulate matter panel discussion--an industry perspective.
    Hammer HF
    J Parenter Sci Technol; 1984; 38(5):170-2. PubMed ID: 6512655
    [No Abstract]   [Full Text] [Related]  

  • 32. Expert systems for parenteral development.
    Rowe RC; Wakerly MG; Roberts RJ; Grundy RU; Upjohn NG
    PDA J Pharm Sci Technol; 1995; 49(5):257-61. PubMed ID: 7489202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleaner medicaments.
    Br Med J; 1973 Apr; 2(5857):6. PubMed ID: 4695717
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Particulate contamination--let's solve the problem.
    Bailey DE
    Am J Hosp Pharm; 1974 Jan; 31(1):30. PubMed ID: 4810163
    [No Abstract]   [Full Text] [Related]  

  • 35. [The origin of particulate contamination in injectable solutions].
    Lambert G; Moës A
    J Pharm Belg; 1972; 27(4):402-16. PubMed ID: 4681074
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [For a strict quality of active pharmaceutical ingredients].
    Astier A
    Ann Pharm Fr; 2008 Mar; 66(2):69-70. PubMed ID: 18570901
    [No Abstract]   [Full Text] [Related]  

  • 38. WHO expert committee on specifications for pharmaceutical preparations. Twenty-fifth report.
    World Health Organ Tech Rep Ser; 1975; (567):1-115. PubMed ID: 807046
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of gum on injection solutions. Foreign particles].
    van Damme PA
    Pharm Acta Helv; 1970 Sep; 45(9):564-71. PubMed ID: 5469386
    [No Abstract]   [Full Text] [Related]  

  • 40. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.